HSP90AA1 and neoplasm: To overcome this barrier, and enable PDT for visceral or diffuse superficial tumors, we developed a strategy for selective tumor targeting of the PS by exploiting molecular signaling unique to cancer, specifically heat shock protein 90 (Hsp90).